The Cooper (BSP:C1OO34) Total Equity : R$37,847 Mil (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is The Cooper Total Equity?

The Cooper's total equity for the quarter that ended in Jan. 2024 was R$37,847 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

The Cooper Total Equity Historical Data

The historical data trend for The Cooper's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Total Equity Chart

The Cooper Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Equity

Get a 7-Day Free Trial

14,813.76

21,515.65

38,469.79

37,682.24

38,177.10

The Cooper Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Total Equity	Get a 7-Day Free Trial															37,048.63	36,140.56	38,177.10	37,847.02	40,034.01

The Cooper Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

The Cooper's Total Equity for the fiscal year that ended in Oct. 2023 is calculated as

Total Equity	=	Total Assets(Q: Oct. 2023 )	-	Total Liabilities(Q: Oct. 2023 )
	=	58946.233	-	20769.132
	=	38,177

The Cooper's Total Equity for the quarter that ended in Jan. 2024 is calculated as

Total Equity	=	Total Assets(Q: Jan. 2024 )	-	Total Liabilities(Q: Jan. 2024 )
	=	59178.733	-	21331.709
	=	37,847

The Cooper Total Equity Related Terms

Thank you for viewing the detailed overview of The Cooper's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper (BSP:C1OO34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (BSP:C1OO34) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

COO:USA COO:Mexico CP6:Germany

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (BSP:C1OO34) Headlines

No Headlines